This week’s View discusses some recent studies that demonstrate advances in coronary artery disease treatment, including the optimal timing for patients with non-ST-elevation acute coronary artery syndrome, the effect of gene therapy in patients with refractory angina, and the impact of microvascular circulation obstruction and adverse events following primary percutaneous coronary intervention.